Evidence-Based GTM: Matthew Terry on Testing What Works for Your Buyers
Matthew Terry of Suade Motion explains why B2B teams need buyer-specific evidence, manual channel tests, and feedback from qualified sales outcomes.
In this article
Evidence-based go-to-market means testing a sales approach against a defined buyer, offer, market, and outcome before treating it as a repeatable playbook. A tactic working for another company is a reason to investigate, not proof it will work for yours.
In his conversation with Enhance AI Partners, Matthew Terry of Suade Motion describes the gap between persuasive sales advice and usable commercial evidence. His starting point was personal: he could build a product and explain its features, yet buyers were not purchasing it.
A product explanation is not a buying reason
Around the opening discussion of his founder journey, Terry recalls presenting the product rather than learning how to sell the outcome. More courses, scripts, and frameworks created information overload without necessarily improving execution.
The distinction matters for founders using AI to prepare outreach. A model can produce an articulate description of your product while missing the reason a particular buyer would change anything.
Before selecting a tactic, define who experiences the problem, why it matters commercially, and what action would count as meaningful interest. If those assumptions remain vague, the experiment will be vague too.
A tool does not carry its own strategy
Terry questions the habit of treating tools as complete solutions. A dialer, email platform, or LinkedIn workflow can support a motion, but cannot establish whether that motion fits the buyer.
He recommends learning through direct, manual activity before automating. That does not mean every company should use cold calling or every channel deserves the same investment. It means the team should observe whether the intended audience can be reached and whether the problem earns attention.
Any pickup-rate or reply-rate examples in a conversation should be read as contextual examples, not universal thresholds. Industry, list quality, sender credibility, and offer all affect the result.
What counts as useful evidence?
Our practical extension of the episode is a short experiment record:
| Field | Question to answer |
|---|---|
| Buyer | Which account type and role are included? |
| Problem | What relevant business condition are we testing? |
| Approach | What channel, message, and next step are used? |
| Exposure | How much comparable outreach occurred? |
| Outcome | What positive replies, held meetings, and opportunities followed? |
| Decision | What will we continue, revise, or stop? |
Preserve negative evidence as carefully as success. “Wrong department” suggests a different issue from “we already solved this” or “the problem is real, but the offer is unsuitable.”
AI needs evidence too
Terry also discusses the risk of AI reproducing weak or irrelevant sales guidance. A confident recommendation is not an observed result. Ask what source supports the advice and whether its market resembles yours.
Use AI to organize replies, compare objections, prepare research, or summarize reviewed sales notes. Do not let it invent expected response rates and then grade the campaign against its own prediction.
For classification, keep the source reply available. A model that labels every polite rejection “positive intent” can make a dashboard look healthy while sales learns very little.
Close the loop beyond the booking
Near the close, Terry makes the case for teams that learn faster rather than simply send more. That requires the outreach system to receive information from the actual sales conversation.
Track whether meetings happened, whether the account fit, what problem was confirmed, and whether an opportunity progressed. Feed those findings into the next audience and message test. Our cold email testing guide turns that principle into a practical experiment structure.
Watch the full episode, explore Suade Motion, or connect with Matthew Terry. Check your fit if your team has plenty of sales activity but little reliable evidence about what works.
Frequently asked questions
- What is evidence-based GTM?
- It is an approach that tests go-to-market assumptions against a defined customer, offer, channel, and commercial outcome. It records what happened and uses the result to shape the next decision.
- Should outbound be automated before it is tested?
- A narrow manual test can expose problems in the audience, message, and offer before automation increases volume. Automate repeatable work once there is enough evidence to justify it, while preserving review and feedback.
- Who is Matthew Terry?
- Matthew Terry is the founder behind Suade Motion and a guest on the Enhance AI Partners Podcast. The conversation covers sales evidence, experimentation, AI tools, and feedback from actual buyer outcomes.
About the author
Yohan Mejia is the CEO of Enhance AI Partners. He brings more than 10 years of go-to-market and paid-acquisition experience and builds AI-powered revenue systems for established B2B companies. Through the Enhance AI Partners podcast, he speaks with founders and operators about the systems behind growth, finance, risk, and automation.
Find where your revenue system is leaking
Answer a few questions to see whether Enhance AI Partners can help you build a more connected and accountable revenue system.
Check your fitRelated reading
- Revenue SystemsHow to Test Cold Email Without Mistaking Replies for Revenue
Plan cold email tests around a clear buyer, one hypothesis, positive replies, qualified meetings, and sales outcomes—not misleading open-rate targets.
- Revenue SystemsLead Scoring: Separate Customer Fit From Buying Intent
Design lead scoring around customer fit and buying intent, with explicit disqualifiers, explainable signals, and a practical review process.
- Revenue SystemsThe Sales Pipeline Dashboard That Tells You What to Fix Next
Build a sales pipeline dashboard around conversion, response time, stage age, next steps, and acquisition cohorts so the team knows where to act.